Skip to content

Enhancing the quality of Life for people with Severe mental health problems through Supported Employment.

A Randomised controlled trial of the cost-effectiveness of Individual Placement and Support in six European countries.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25341
Enrollment
300
Registered
2005-09-09
Start date
2003-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe mental health problems.

Interventions

Individual PLacement and Support (EXP) will be compared to standard vocational rehabilitation (CC).

Sponsors

Great Brittain: Prof. T. Burns, London/Oxford, The Netherlands: Prof. dr D. Wiersma, Groningen. Italy: Prof. A. Fioriti, Rimini. Switzerland: W. Rossler, Zurich. Germany: Prof. dr. T. Becker, Ulm. Bulgary: Prof. dr. T. Tomov, Sofia.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of a serious mental illness: schizophrenia, schzophrenia-like disorders, bipolardisorder with psychotic features; 2. Age 18-65 years; 3. Living in the community at baseline; 4. Not employed for more then a month in the year before the start of the study; 5. In mental health care for more then two years; 6. Interest in competitive employment; 7. Willing to give informed consent.

Exclusion criteria

Exclusion criteria: Use of the EXP or CC service in the preceding year.

Design outcomes

Primary

MeasureTime frame
1. Achievement of open, paid employment; 2. Hours of open employment; 3. Time in open employment.

Secondary

MeasureTime frame
1. Clinical improvement; 2. Hospital admissions; 3. (un-met) needs for care; 4. Quality of life.

Contacts

Public ContactJ.T. Busschbach, van

University Medical Center Groningen (UMCG), Rob Giel Research Center, P.O. Box 30001

j.t.van.busschbach@med.umcg.nl+31 (0)50 3612069

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)